Skip to main content

Advertisement

Table 2 Antibiotic resistance patterns of isolates (number showing resistance / isolates with antibiotic sensitivity data available)

From: Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli

  Consolidation 1 Consolidation 2
  (% of isolates) (% of isolates)
CNST 20 (37.7%) 23 (32.4%)
Vancomycin resistant 1 / 15 0 / 21
Cloxacillin resistant 14 / 17 21 / 22
Streptococcus species 9 (17%) 17 (23.9%)
Penicillin resistant 1 / 7 0 / 11
Vancomycin resistant 0 / 3 0 / 6
Gram Negatives 11 (20.7%) 20 (28.1%)
Ciprofloxacin resistant 2 / 10 8 / 15
P/T* resistant 1 / 10 0 / 14
Ampicillin resistant 9 / 9 13 / 15
Tobramycin resistant 1 / 8 3 / 10
Klebsiella species 2 (3.8%) 5 (7.0%)
Ciprofloxacin resistant 0/2 0 / 4
P/T* resistant 0/2 0 / 4
Ampicillin resistant 2/2 4 / 4
Tobramycin resistant 0/2 0 / 3
Escherichia coli 1 (1.9%) 10 (14.1%)
Ciprofloxacin resistant 1/1 8 / 8
P/T* resistant 0 / 1 0 / 8
Ampicillin resistant 1 / 1 7 / 8
Tobramycin resistant 1/1 3 / 5
Pseudomonas species 4 (7.6%) -
Ciprofloxacin resistant 1 / 4 -
P/T* resistant 1/1 -
Ampicillin resistant 3/3 -
Tobramycin resistant 0 / 4 -
  1. *P/T = Piperacillin/tazobactam.